The Effectiveness and Safety of Cleanser Containing Triethyl Citrate, Pyruvic Acid, Combination Cream Containing Triethyl Citrate, Ethyl Linoleate, GT Peptide-10, Salicylic Acid 0,5%, Zinc Lactate, Hyaluronic Acid and Spot Cream Containing Triethyl Citrate, Ethyl Linoleate, GT Peptide-10, Honokiol

Launched by DR.DR.IRMA BERNADETTE, SPKK (K) · Jan 13, 2025

Keywords

ClinConnect Summary

This clinical trial is studying the effectiveness and safety of a new skincare routine for treating mild to moderate acne, which includes a cleanser and two types of creams. The aim is to see how well these products work together to help clear up acne and whether they are safe for people to use. Participants in the study will be men and women aged between 15 and 50 years who have mild to moderate acne.

If you qualify and decide to take part, you'll use the specified skincare products and have check-ins with a dermatologist at set intervals over 84 days. During these visits, your skin will be examined and photographed to track any changes. It’s important to note that participants should not have any allergies to skincare products and should not be using other acne treatments or medications prior to the study. This trial is not currently recruiting participants, but it aims to provide valuable information about new options for acne treatment.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Female and male aged 15-50 years
• • mild to moderate acne vulgaris according to IAEM (Indonesian Acne Expert Meeting) scale and GEA ( Global Acne Severity) scale
• • The subject is willing to participate in the study until it is finished
• Exclusion Criteria:
• • History of allergy to dermocosmetic products
• • Undergoing other acne therapy, medication, or invasive action in the last month
• • Pregnant or breastfeeding subjects